Concord Biotech Limited (NSE:CONCORDBIO)
India
· Delayed Price · Currency is INR 1,754.90
-2.30 (-0.13%)
Jul 3, 2025, 10:30 AM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 183.83 billion as of July 2, 2025. Its market cap has increased by 21.63% in one year.
Market Cap
183.83B
Enterprise Value
180.68B
Revenue
12.00B
Ranking
n/a
PE Ratio
49.47
Stock Price
1,754.90
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 183.83B, an increase of 86.38%. That is a compound annual growth rate of 39.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 183.83B | -20.52% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,020.57B |
| Divi's Laboratories | 1,807.71B |
| Cipla | 1,216.33B |
| Apollo Hospitals Enterprise | 1,041.29B |
| Zydus Lifesciences | 996.12B |
| Mankind Pharma | 957.45B |
| Aurobindo Pharma | 659.09B |
| Fortis Healthcare | 599.81B |